Mortality


Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined by elevated NT-proBNP concentrations over 3 years—was associated with substantially higher risks of CVD and all-cause mortality, whereas HS remission was associated with risks similar to those of individuals who remained HS-free. In the observational […]


Left Ventricular Size and Mortality Risk in Heart Failure

A Chinese nationwide study of 273,921 patients hospitalized with heart failure (HF) found a U-shaped association between left ventricular end-diastolic diameter (LVEDD) and mortality, with both abnormally small and abnormally large left ventricles independently associated with higher all-cause mortality. Using data from the Chinese Cardiovascular Association Database–Heart Failure Center Registry, […]


Testosterone Therapy Without Hypogonadism Linked to Higher Long-Term Cardiovascular Risk

Men who started testosterone therapy (TT) without evidence of hypogonadism had significantly higher long-term risks of major adverse cardiovascular events (MACE), all-cause mortality, ischaemic stroke, cardiac arrest, and heart failure than men with documented hypogonadism. In this global retrospective real-world study of 358,957 men aged 30–75 years initiating TT, 35.4% […]


SGLT2 Inhibitor Use After Takotsubo Syndrome Linked to Lower Mortality

Early initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors after Takotsubo syndrome was associated with significantly lower all-cause mortality in a large real-world U.S. study, although reductions in cardiovascular complications were not observed. Using the TriNetX U.S. Collaborative Network, researchers identified adults diagnosed with Takotsubo syndrome between 2015 and 2025 and compared […]


Carotid-Artery Stenting Beneficial for Carotid Stenosis

Adding carotid-artery stenting—but not carotid endarterectomy—to intensive medical management reduced the risk of stroke or death in patients with high-grade asymptomatic carotid stenosis. In two parallel, observer-blinded trials including more than 2,400 participants with ≥70% stenosis, the 4-year incidence of the primary composite outcome (any stroke or death from randomization […]